Human pegivirus-1 replication influences NK cell reconstitution after allogeneic haematopoietic stem cell transplantation
暂无分享,去创建一个
A. Pradier | S. Cordey | Y. Chalandon | S. Masouridi-Levrat | F. Simonetta | D. Vu | A. Melotti | M. Zanella | L. Kaiser | Sisi Wang | Anne-Claire Mamez
[1] A. Mrzljak,et al. Human pegivirus infection after transplant: Is there an impact? , 2022, World journal of transplantation.
[2] I. Melero,et al. Killers on the loose: Immunotherapeutic strategies to improve NK cell-based therapy for cancer treatment. , 2022, International review of cell and molecular biology.
[3] M. Docquier,et al. Unmasking viral sequences by metagenomic next-generation sequencing in adult human blood samples during steroid-refractory/dependent graft-versus-host disease , 2021, Microbiome.
[4] R. Chakraverty,et al. Graft Versus Leukemia: Current Status and Future Perspectives. , 2021, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[5] M. V. D. van den Brink,et al. T cell regeneration after immunological injury , 2020, Nature Reviews Immunology.
[6] L. Kaiser,et al. Beyond Cytomegalovirus and Epstein-Barr Virus: a Review of Viruses Composing the Blood Virome of Solid Organ Transplant and Hematopoietic Stem Cell Transplant Recipients , 2020, Clinical Microbiology Reviews.
[7] H. Sengeløv,et al. Improved Relapse-Free Survival in Patients With High Natural Killer Cell Doses in Grafts and During Early Immune Reconstitution After Allogeneic Stem Cell Transplantation , 2020, Frontiers in Immunology.
[8] M. Biernacki,et al. T cell optimization for graft-versus-leukemia responses. , 2020, JCI insight.
[9] D. Longo,et al. Minimal PD-1 expression in mouse and human NK cells under diverse conditions. , 2020, The Journal of clinical investigation.
[10] J. Falkenburg,et al. Bone marrow central memory and memory stem T-cell exhaustion in AML patients relapsing after HSCT , 2019, Nature Communications.
[11] L. Vago,et al. Mechanisms of immune escape after allogeneic hematopoietic cell transplantation. , 2019, Blood.
[12] E. Zdobnov,et al. Human pegivirus persistence in human blood virome after allogeneic haematopoietic stem-cell transplantation. , 2019, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[13] María Blanca Fernández-Viñéa. CURRENT STATUS AND FUTURE PERSPECTIVES , 2018 .
[14] R. Negrin,et al. Natural Killer Cells in Graft-versus-Host-Disease after Allogeneic Hematopoietic Cell Transplantation , 2017, Front. Immunol..
[15] L. Kaiser,et al. The concept of commensal viruses almost 20 years later: redefining borders in clinical virology , 2017, Clinical Microbiology and Infection.
[16] H. Marquart,et al. Early Natural Killer Cell Reconstitution Predicts Overall Survival in T Cell-Replete Allogeneic Hematopoietic Stem Cell Transplantation. , 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[17] J. McLinden,et al. Human Pegivirus (HPgV; formerly known as GBV-C) inhibits IL-12 dependent natural killer cell function. , 2015, Virology.
[18] A. Pradier,et al. NK Cell Functional Impairment after Allogeneic Hematopoietic Stem Cell Transplantation Is Associated with Reduced Levels of T-bet and Eomesodermin , 2015, The Journal of Immunology.
[19] J. Stapleton,et al. Tropism of human pegivirus (formerly known as GB virus C/hepatitis G virus) and host immunomodulation: insights into a highly successful viral infection. , 2015, The Journal of general virology.
[20] M. Winters,et al. Human pegivirus RNA is found in multiple blood mononuclear cells in vivo and serum-derived viral RNA-containing particles are infectious in vitro. , 2014, The Journal of general virology.
[21] Herbert W Virgin,et al. The Virome in Mammalian Physiology and Disease , 2014, Cell.
[22] E. Riley,et al. Functional Significance of CD57 Expression on Human NK Cells and Relevance to Disease , 2013, Front. Immunol..
[23] A. Landay,et al. GB virus C infection and B-cell, natural killer cell, and monocyte activation markers in HIV-infected individuals , 2013, AIDS.
[24] A. Landay,et al. GB Virus C Particles Inhibit T Cell Activation via Envelope E2 Protein-Mediated Inhibition of TCR Signaling , 2013, The Journal of Immunology.
[25] K. Chaloner,et al. GB Virus C Infection Is Associated with Altered Lymphocyte Subset Distribution and Reduced T Cell Activation and Proliferation in HIV-Infected Individuals , 2012, PloS one.
[26] J. Stapleton,et al. GB virus C viremia is associated with higher levels of double-negative T cells and lower T-cell activation in HIV-infected individuals receiving antiretroviral therapy. , 2012, The Journal of infectious diseases.
[27] J. Stapleton,et al. Gb Virus C Infection is Associated with a Reduced Rate of Reactivation of Latent HIV and Protection against Activation-Induced T-Cell Death , 2012, Antiviral therapy.
[28] G. Rutherford,et al. Acquisition of GB virus type C and lower mortality in patients with advanced HIV disease. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[29] J. Passweg,et al. CD56bright NK cells after hematopoietic stem cell transplantation are activated mature NK cells that expand in patients with low numbers of T cells , 2010, European journal of immunology.
[30] J. Schold,et al. The relationship between circulating natural killer cells after reduced intensity conditioning hematopoietic stem cell transplantation and relapse-free survival and graft-versus-host disease , 2008, Haematologica.
[31] J. Passweg,et al. Reconstitution of the immune system after hematopoietic stem cell transplantation in humans , 2008, Seminars in Immunopathology.
[32] M. Robin,et al. An Unusual CD56brightCD16low NK Cell Subset Dominates the Early Posttransplant Period following HLA-Matched Hematopoietic Stem Cell Transplantation1 , 2008, The Journal of Immunology.
[33] Marcela R. Uribe,et al. Rapid natural killer cell recovery determines outcome after T-cell-depleted HLA-identical stem cell transplantation in patients with myeloid leukemias but not with acute lymphoblastic leukemia , 2007, Leukemia.
[34] M. Martelli,et al. Donor natural killer cell allorecognition of missing self in haploidentical hematopoietic transplantation for acute myeloid leukemia: challenging its predictive value. , 2006, Blood.
[35] K. Chaloner,et al. Effect of early and late GB virus C viraemia on survival of HIV‐infected individuals: a meta‐analysis , 2006, HIV medicine.
[36] A. Gratwohl,et al. Reconstitution of dendritic and natural killer-cell subsets after allogeneic stem cell transplantation: effects of endogenous flt3 ligand. , 2004, Blood.
[37] Todd A Fehniger,et al. Natural killer cell receptors: new biology and insights into the graft-versus-leukemia effect. , 2002, Blood.
[38] Katia Perruccio,et al. Effectiveness of Donor Natural Killer Cell Alloreactivity in Mismatched Hematopoietic Transplants , 2002, Science.
[39] R. Wesley,et al. The incidence of transfusion-associated hepatitis G virus infection and its relation to liver disease. , 1997, The New England journal of medicine.